36627411000001108: Bendamustine 180mg/4ml solution for infusion vials (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual medicinal product\Bendamustine 180mg/4ml solution for infusion vials
\UK product\Virtual therapeutic moiety\Bendamustine\Bendamustine 180mg/4ml solution for infusion vials

\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Medicinal product containing purine analog and acting as antineoplastic agent (product)\Product containing bendamustine\Bendamustine\Bendamustine 180mg/4ml solution for infusion vials
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing alkylating agent\Medicinal product containing nitrogen mustard derivative and acting as antineoplastic agent (product)\Product containing bendamustine\Bendamustine\Bendamustine 180mg/4ml solution for infusion vials
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing purine and/or purine derivative (product)\Medicinal product containing purine analog and acting as antineoplastic agent (product)\Product containing bendamustine\Bendamustine\Bendamustine 180mg/4ml solution for infusion vials
\Medicinal product\Medicinal product categorized by structure\Product containing benzimidazole\Product containing bendamustine\Bendamustine\Bendamustine 180mg/4ml solution for infusion vials
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing nitrogen mustard derivative and acting as antineoplastic agent (product)\Product containing bendamustine\Bendamustine\Bendamustine 180mg/4ml solution for infusion vials
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing purine analog and acting as antineoplastic agent (product)\Product containing bendamustine\Bendamustine\Bendamustine 180mg/4ml solution for infusion vials

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Feb 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

112484501000001117 Bendamustine 180mg/4ml solution for infusion vials (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

112484601000001118 Bendamustine 180mg/4ml solution for infusion vials en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Bendamustine 180mg/4ml solution for infusion vials	Is a	Bendamustine	true	Inferred relationship	Existential restriction modifier
Bendamustine 180mg/4ml solution for infusion vials	Has NHS dm+d (dictionary of medicines and devices) dose form indicator	Discrete dose form indicator	true	Inferred relationship	Existential restriction modifier
Bendamustine 180mg/4ml solution for infusion vials	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Bendamustine 180mg/4ml solution for infusion vials	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration	Intravenous route	true	Inferred relationship	Existential restriction modifier
Bendamustine 180mg/4ml solution for infusion vials	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route	solutioninfusion.intravenous ontology form and route	true	Inferred relationship	Existential restriction modifier
Bendamustine 180mg/4ml solution for infusion vials	Plays role	Antineoplastic therapeutic role	true	Inferred relationship	Existential restriction modifier
Bendamustine 180mg/4ml solution for infusion vials	Is a	Product containing bendamustine	false	Inferred relationship	Existential restriction modifier
Bendamustine 180mg/4ml solution for infusion vials	Has active ingredient	Bendamustine	false	Inferred relationship	Existential restriction modifier
Bendamustine 180mg/4ml solution for infusion vials	Has dispensed dose form	Conventional release solution for infusion	true	Inferred relationship	Existential restriction modifier
Bendamustine 180mg/4ml solution for infusion vials	Has specific active ingredient	Bendamustine hydrochloride	true	Inferred relationship	Existential restriction modifier
Bendamustine 180mg/4ml solution for infusion vials	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Bendamustine 180mg/4ml solution for infusion vials	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Bendamustine 180mg/4ml solution for infusion vials	Is a	Virtual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Bendamustine 180mg/4ml concentrate for solution for infusion vials (Dr Reddy's Laboratories (UK) Ltd)	Is a	True	Bendamustine 180mg/4ml solution for infusion vials	Inferred relationship	Existential restriction modifier
Bendamustine 180mg/4ml solution for infusion vials 1 vial	Has VMP	True	Bendamustine 180mg/4ml solution for infusion vials	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
112484501000001117	Bendamustine 180mg/4ml solution for infusion vials (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
112484601000001118	Bendamustine 180mg/4ml solution for infusion vials	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module